T. Rowe Price Associates’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$428M Buy
7,211,260
+953,456
+15% +$46M 0.05% 275
2025
Q4
$245M Sell
6,257,804
-56,976
-0.9% -$2.21M 0.03% 405
2025
Q3
$255M Buy
6,314,780
+3,633,181
+135% +$148M 0.03% 403
2025
Q2
$102M Buy
2,681,599
+425,318
+19% +$15.6M 0.01% 566
2025
Q1
$96.6M Sell
2,256,281
-202,600
-8% -$8.65M 0.01% 557
2024
Q4
$99.6M Buy
2,458,881
+2,312,292
+1,577% +$96.3M 0.01% 564
2024
Q3
$5.62M Buy
146,589
+2,612
+2% +$113K ﹤0.01% 1259
2024
Q2
$6.75M Sell
143,977
-907
-0.6% -$45.7K ﹤0.01% 1171
2024
Q1
$7.52M Sell
144,884
-18,806
-11% -$856K ﹤0.01% 1154
2023
Q4
$7.19M Buy
163,690
+8,238
+5% +$376K ﹤0.01% 1155
2023
Q3
$7.4M Sell
155,452
-23,886
-13% -$1.08M ﹤0.01% 1117
2023
Q2
$6.83M Buy
179,338
+12,860
+8% +$465K ﹤0.01% 1136
2023
Q1
$6.01M Sell
166,478
-30,239
-15% -$1.33M ﹤0.01% 1142
2022
Q4
$9.97M Sell
196,717
-13,675
-6% -$715K ﹤0.01% 1055
2022
Q3
$9.68M Buy
210,392
+45,314
+27% +$2.16M ﹤0.01% 1071
2022
Q2
$7.29M Buy
165,078
+19,727
+14% +$1.02M ﹤0.01% 1370
2022
Q1
$7.86M Buy
145,351
+30,555
+27% +$1.32M ﹤0.01% 1403
2021
Q4
$3.87M Sell
114,796
-1,608
-1% -$57.4K ﹤0.01% 1533
2021
Q3
$3.83M Sell
116,404
-5,282
-4% -$146K ﹤0.01% 1547
2021
Q2
$3.83M Sell
121,686
-2,047
-2% -$55K ﹤0.01% 1565
2021
Q1
$2.95M Buy
123,733
+1,065
+0.9% +$22.8K ﹤0.01% 1586
2020
Q4
$1.76M Sell
122,668
-9,633,465
-99% -$113M ﹤0.01% 1687
2020
Q3
$79.6M Sell
9,756,133
-5,742,095
-37% -$59.2M 0.01% 722
2020
Q2
$148M Buy
15,498,228
+1,061,048
+7% +$7.4M 0.02% 540
2020
Q1
$39M Buy
14,437,180
+7,457,464
+107% +$97.9M 0.01% 860
2019
Q4
$164M Buy
6,979,716
+6,967,256
+55,917% +$149M 0.02% 521
2019
Q3
$286K Sell
12,460
-853,830
-99% -$19.6M ﹤0.01% 2304
2019
Q2
$22.2M Sell
866,290
-12,404
-1% -$387K ﹤0.01% 1150
2019
Q1
$31.8M Buy
878,694
+4,832
+0.6% +$166K ﹤0.01% 1027
2018
Q4
$25.3M Sell
873,862
-849,762
-49% -$36.6M ﹤0.01% 1073
2018
Q3
$113M Buy
1,723,624
+1,038,048
+151% +$67.3M 0.02% 630
2018
Q2
$44.7M Sell
685,576
-55,064
-7% -$3.45M 0.01% 940
2018
Q1
$40.7M Sell
740,640
-436,808
-37% -$25.9M 0.01% 949
2017
Q4
$78.5M Sell
1,177,448
-1,419,989
-55% -$83.8M 0.01% 717
2017
Q3
$153M Buy
2,597,437
+1,695,074
+188% +$82.8M 0.03% 503
2017
Q2
$39.7M Buy
902,363
+31,599
+4% +$1.64M 0.01% 920
2017
Q1
$51M Sell
870,764
-2,151,334
-71% -$129M 0.01% 799
2016
Q4
$177M Buy
3,022,098
+2,010,946
+199% +$115M 0.04% 445
2016
Q3
$52.9M Buy
1,011,152
+1,006,172
+20,204% +$45.1M 0.01% 784
2016
Q2
$193K Buy
4,980
+940
+23% +$34.4K ﹤0.01% 2341
2016
Q1
$124K Hold
4,040
﹤0.01% 2384
2015
Q4
$102K Sell
4,040
-840
-17% -$30.7K ﹤0.01% 2418
2015
Q3
$156K Hold
4,880
﹤0.01% 2337
2015
Q2
$269K Buy
+4,880
New +$310K ﹤0.01% 2242

Other funds holding OVV

T. Rowe Price Associates's OVV Position: Q1 2026 in Review

T. Rowe Price Associates increased its Ovintiv (OVV) stake by 15% in Q1 2026, buying an estimated $46M and bringing the position to 7,211,260 shares worth $428M. The position accounts for 0.05% of the portfolio, ranked #275.

T. Rowe Price Associates first reported a position in OVV in Q2 2015 and has held it in 44 quarters since. 609 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • T. Rowe Price Associates held 7,211,260 shares of Ovintiv worth $428M as of Q1 2026.
  • T. Rowe Price Associates bought 953,456 Ovintiv shares in Q1 2026, an estimated $46M.
  • Ovintiv made up 0.05% of T. Rowe Price Associates's portfolio in Q1 2026, its #275 holding.
  • T. Rowe Price Associates first reported a position in Ovintiv in Q2 2015 and has held it in 44 quarters since.
  • 609 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.